Affini-T Therapeutics pulls in $175m

Affini-T Therapeutics, Inc., a biotechnology company, has raised $175 million in financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this